Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasmin Polak

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Peptides|January 5, 2021
Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activityYasmin Polak, Robert C Speth
Frontiers in Pharmacology|October 15, 2021
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic AcidYasmin Polak, Bart A W Jacobs, E Marleen Kemper
Pharmaceutics|March 29, 2023
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis DefectsYasmin Polak, Bart A W Jacobs, Natalja Bouwhuis, et al.
Orphanet Journal of Rare Diseases|December 20, 2024
The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic reviewYasmin Polak, Laura van Dussen, E Marleen Kemper, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 17, 2023
[Medicine compounding in the pharmacy]Yasmin Polak, Bart A W Jacobs, Sibren van den Berg, et al.
Journal of Inherited Metabolic Disease|July 11, 2025
Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis DefectsYasmin Polak, Elles Marleen Kemper, Marc Engelen, et al.
Journal of Inherited Metabolic Disease|March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous XanthomatosisNatalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Peptides|January 5, 2021
Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activityYasmin Polak, Robert C Speth
Frontiers in Pharmacology|October 15, 2021
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic AcidYasmin Polak, Bart A W Jacobs, E Marleen Kemper
Pharmaceutics|March 29, 2023
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis DefectsYasmin Polak, Bart A W Jacobs, Natalja Bouwhuis, et al.
Orphanet Journal of Rare Diseases|December 20, 2024
The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic reviewYasmin Polak, Laura van Dussen, E Marleen Kemper, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 17, 2023
[Medicine compounding in the pharmacy]Yasmin Polak, Bart A W Jacobs, Sibren van den Berg, et al.
Journal of Inherited Metabolic Disease|July 11, 2025
Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis DefectsYasmin Polak, Elles Marleen Kemper, Marc Engelen, et al.
Journal of Inherited Metabolic Disease|March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous XanthomatosisNatalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Pageof 1